Vifor Pharma AG - ESG Rating & Company Profile powered by AI
This report of Vifor Pharma AG was prepared by All Street Sevva using cutting edge artificial intelligence. This Disclosure rating includes seventeen United Nations Sustainable Development Goals including: 'Zero Hunger', 'Climate Action' and 'Life below Water'. If you work at Vifor Pharma AG and you wish to use your Sustainability aseessment, please contact us.
Vifor Pharma AG in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.1; made up of an environmental score of 1.3, social score of 2.3 and governance score of 2.7.
2.1
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1551 | Voyager Life PLC | 2.2 | Medium |
| 1551 | Source Natural Foods and Herbal Supplements Ltd | 2.2 | Medium |
| 1571 | Vifor Pharma AG | 2.1 | Medium |
| 1571 | Cerevel Therapeutics Holdings Inc | 2.1 | Medium |
| 1571 | Charlotte's Web Holdings Inc | 2.1 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Vifor Pharma AG have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Vifor Pharma AG disclose current and historical energy intensity?
Sign up for free to unlockDoes Vifor Pharma AG report the average age of the workforce?
Sign up for free to unlockDoes Vifor Pharma AG reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Vifor Pharma AG disclose its ethnicity pay gap?
Sign up for free to unlockDoes Vifor Pharma AG disclose cybersecurity risks?
Sign up for free to unlockDoes Vifor Pharma AG offer flexible work?
Sign up for free to unlockDoes Vifor Pharma AG have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Vifor Pharma AG disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Vifor Pharma AG conduct supply chain audits?
Sign up for free to unlockDoes Vifor Pharma AG disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Vifor Pharma AG conduct 360 degree staff reviews?
Sign up for free to unlockDoes Vifor Pharma AG disclose the individual responsible for D&I?
Sign up for free to unlockDoes Vifor Pharma AG disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Vifor Pharma AG disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Vifor Pharma AG disclose water use targets?
Sign up for free to unlockDoes Vifor Pharma AG have careers partnerships with academic institutions?
Sign up for free to unlockDid Vifor Pharma AG have a product recall in the last two years?
Sign up for free to unlockDoes Vifor Pharma AG disclose incidents of discrimination?
Sign up for free to unlockDoes Vifor Pharma AG allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Vifor Pharma AG issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Vifor Pharma AG disclose parental leave metrics?
Sign up for free to unlockDoes Vifor Pharma AG disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Vifor Pharma AG disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Vifor Pharma AG disclose the pay ratio of women to men?
Sign up for free to unlockDoes Vifor Pharma AG support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Vifor Pharma AG disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Vifor Pharma AG reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Vifor Pharma AG involved in embryonic stem cell research?
Sign up for free to unlockDoes Vifor Pharma AG disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Vifor Pharma AG disclose its waste policy?
Sign up for free to unlockDoes Vifor Pharma AG report according to TCFD requirements?
Sign up for free to unlockDoes Vifor Pharma AG disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Vifor Pharma AG disclose energy use targets?
Sign up for free to unlockDoes Vifor Pharma AG disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Vifor Pharma AG have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Vifor Pharma AG
These potential risks are based on the size, segment and geographies of the company.
Vifor Pharma AG, a pharmaceutical company, focuses on the development, manufacture, and commercialization of pharmaceutical products in Switzerland, rest of Europe, the United States, and internationally. The company offers Ferinject/Injectafer, a solution of ferric carboxymaltose used for the treatment of iron deficiency and iron deficiency anemia; Maltofer, an oral iron polymaltose complex for infants, children, adolescents, and pregnant woman with iron deficiency; and Mircera, a long-acting erythropoiesis-stimulating agent (ESA) to treat symptomatic anemia associated with the chronic kidney disease (CKD).It also provides Retacrit, a short-acting ESA; Venofer, an intravenous iron sucrose used in the intravenous treatment of iron deficiency; and Velphoro, a non-calcium, iron-based chewable phosphate binder for the treatment of hyperphosphatemia in adults with CKD undergoing dialysis. In addition, the company offers Rayaldee, an orally administered, extended release formulation of calcifediol for the treatment of secondary hyperparathyroidism in patients with CKD; and Veltassa for the treatment of hyperkalemia in CKD and chronic heart failure patients. Further, it develops Vadadustat, an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of altitude on oxygen availability; Avacopan, an orally-administered, highly selective inhibitor of C5aR1 for the treatment of orphan and rare renal diseases;ANG-3777 for the treatment of transplant-associated acute kidney injury; Difelikefalin for the treatment for chronic kidney disease-associated pruritus; and VIT-2763 to treat beta-thalassemia. Vifor Pharma AG has a strategic partnership with Fresenius Kabi and Zeria Pharmaceutical. The company was founded in 1872 and is headquartered in Sankt Gallen, Switzerland. As of August 9, 2022, Vifor Pharma AG operates as a subsidiary of CSL Behring AG.